Form 4 for AMLX Amylyx Pharmaceuticals, Inc.
Accepted 2026-01-14 00:00:00 ET · period of report 2026-01-12 · accession 0001193125-26-012921 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-14 | 2026-01-12 | AMLX | MILNE GEORGE M JR | Dir | G - Gift | $0.00 | -17.8K | 812.9K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-12 | G | D | 17,780 | $0.00 | 812,881 | D | — | — |